BNP Paribas Financial Markets Cuts Stock Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

BNP Paribas Financial Markets lessened its holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 94.2% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 16,189 shares of the company's stock after selling 265,031 shares during the period. BNP Paribas Financial Markets' holdings in Acadia Healthcare were worth $642,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of the business. Lindbrook Capital LLC raised its position in shares of Acadia Healthcare by 1,342.0% in the fourth quarter. Lindbrook Capital LLC now owns 721 shares of the company's stock valued at $29,000 after purchasing an additional 671 shares during the period. Blue Trust Inc. lifted its stake in Acadia Healthcare by 69.4% in the fourth quarter. Blue Trust Inc. now owns 842 shares of the company's stock worth $33,000 after purchasing an additional 345 shares during the last quarter. Nisa Investment Advisors LLC increased its position in shares of Acadia Healthcare by 40.7% in the fourth quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company's stock valued at $41,000 after acquiring an additional 301 shares during the period. Signaturefd LLC raised its stake in shares of Acadia Healthcare by 460.6% during the fourth quarter. Signaturefd LLC now owns 1,222 shares of the company's stock valued at $48,000 after acquiring an additional 1,004 shares during the last quarter. Finally, Fifth Third Bancorp boosted its holdings in shares of Acadia Healthcare by 56.0% during the fourth quarter. Fifth Third Bancorp now owns 1,264 shares of the company's stock worth $50,000 after purchasing an additional 454 shares during the period.

Acadia Healthcare Stock Performance

ACHC traded up $0.99 during trading on Tuesday, hitting $23.52. The company's stock had a trading volume of 1,299,851 shares, compared to its average volume of 1,720,509. Acadia Healthcare Company, Inc. has a one year low of $20.36 and a one year high of $82.41. The business's 50 day simple moving average is $25.56 and its 200-day simple moving average is $34.72. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. The firm has a market cap of $2.17 billion, a PE ratio of 7.71, a P/E/G ratio of 1.46 and a beta of 1.01.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last released its quarterly earnings results on Monday, May 12th. The company reported $0.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.35 by $0.05. The business had revenue of $770.51 million during the quarter, compared to analyst estimates of $769.90 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. Acadia Healthcare's revenue for the quarter was up .3% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.84 earnings per share. As a group, sell-side analysts predict that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the stock. Wall Street Zen raised shares of Acadia Healthcare from a "sell" rating to a "hold" rating in a research note on Thursday, May 22nd. Royal Bank of Canada cut their price target on shares of Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating on the stock in a report on Monday, March 3rd. Bank of America reduced their target price on Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating for the company in a report on Friday, February 28th. Mizuho dropped their price objective on Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating on the stock in a research report on Wednesday, May 14th. Finally, Guggenheim assumed coverage on Acadia Healthcare in a research report on Wednesday, April 9th. They issued a "buy" rating and a $36.00 target price for the company. Four equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $47.94.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.